It was then that I decided I wanted, not needed, to see a myeloma specialist at the Princess Margaret Cancer Centre (PMCC) - one of the top 5 research centres in the world. As I began to educate myself on new drugs being developed and new clinical trials, it made me feel like I was doing something even though I was still on a watch and wait.
In 2015 I learned about a new drug called daratumamab (Darzalex) and a clinical trial at the PMCC. I think I surprised my doctor when I brought it up long before the trial start date at PMCC. This was a trial for smouldering myeloma patients. At that time, trials for smouldering patients were very rare. Once the trial opened, my doctor, my husband and the trial coordinator discussed the pros and cons and decided that I was a good candidate for the trial. There was much paperwork to review and sign. I cannot describe how happy I was to finally be doing something about this disease. To be one of the first people in Canada to be treated with daratumamab was very exciting as there seemed to be few major side effects reported and preliminary results were promising.
My journey began with testing for the clinical trial. I must say that I have never had such an extensive and exhaustive health work-up in my life. I got to listen to the sound the chambers of my heart make during an ultrasound. It sounds like a symphony of classical music – it really does! I was put in a clear plastic box for pulmonary function testing, just like the ones that you see on TV where game show contestants try to grab dollar bills swirling in the air. I had a full-body MRI. I must confess that I am one of the few people who don’t mind this test. I find it relaxing being in the tube with a warm blanket over me. The pulsing sounds of the machine lull me to sleep.
Unfortunately, that MRI discovered a lesion on my T10 vertebrae and my M protein and IgA levels quickly increased. I was disqualified from the trial and that was incredibly disappointing. I was devastated but I called Myeloma Canada and the person I spoke with was incredibly supportive and reminded me that I was very lucky that all these changes were caught so quickly before there was any significant organ damage.
I had a bone marrow aspiration in my spine which confirmed the presence of myeloma cells. My specialist and the team at PMCC recommended a stem cell transplant. What a whirlwind that was! In just a few weeks, I went from being a candidate for a trial to an active myeloma patient. I began with four cycles of CyBorD which is Velcade (bortezomib), dexamethasone and cyclophosimide. Each cycle lasted a month. I made so many trips to the PMCC that I was on a first-name basis with many of the nurses. It was not an easy time, but my doctor and nurses really got me through it and supported me all the way.
I received a call on the afternoon of April 30,
2016, advising me that a bed was ready and I needed to be at the hospital by 7pm that evening. I was in the hospital until May 16.
Maintaining a positive attitude has helped me immensely. This doesn’t mean that there were not more difficult days. Every day I got up, showered, and got dressed and sometimes that was all that I could bring myself to do but I did it every day!